1 Jones PH et al. Am J Cardiol 2003;92:152–160

2 Schuster H, Barter P, Stender S et al. Am Heart J2004;147:705–712.

3 Blasetto JW, Stein EA, Brown WV et al. Am J Cardiol2003;91(Suppl):3C–10C.

4 Berne C, Siewart-Delle A. Cardiovascular Diabetology 2005; 4:7

5 Betteridge JD, Gibson M. Atheroscler Suppl 2004;5(1):107, Abs M464.

6 Davidson M, Ma P, Stein EA et al. Am J Cardiol 2002;89:268–275.

7 Schwartz GG, Bolognese MA, Tremblay BP et al. Am Heart J 2004; 148(1):P105, H1–H9.

8 Olsson AG, Istad H, Luurila O et al. Am Heart J 2002;144:1044–1051.

9 Stalenhoef A, Ballantyne C, Sarti C et al. Eur Heart J 2005; 26:2664-2672.

10 Strandberg TE, Freely J, Sigurdsson E. Clin Ther 2004;26(11):1821–1833.

11 Gupta M, Constance C. Atheroscler Suppl 2005;6(1):108-109 Abs W16-P-033.

12 Fonseca FAH, Marotti M et al. Curr Med Res Opin 2005;21(8):1307-1315.

13 Jukema J, Liem A, Dunselman P et al. Curr Med Res Opin 2005; 21(11):1864-1876.

14 Clearfield M, Kallend D, Palmer M et al. Atheroscler Suppl 2005;6(1):104 Abs W16-P-014.

15 Wolffenbuttel B, Franken A, Vincent H et al. J Int Med 2005; 257:531–539.

16 Paoletti R, Fahmy M, Mahla G et al. J Cardiovasc Risk 2001;8:383–390.

17 Brown W, Bays HE, Hassman DR et al. Am Heart J 2002;144:1036–1043.

18 Ferdinand K, Clark L, Watson K et al. Am J Cardiol 2006;97(2):229-235.

19 Lloret R, Haffner S, Ycas J, Stein M. Am J Cardiol 2006;98(6):768-773

20 Deedwania P, Gupta M, Stein M et al. Atheroscler Suppl 2006; 7(3):161 Abs Tu-W20:6

21 Faergeman O, Sosef F, Duffield E. Atheroscler Suppl 2006;7(3):580 Abs Th-P16:394

22 Bots A, Kastelein J. Int J Clin Pract 2005;59(12):1387-94.

23 Middleton A, Fuat A. Br J Cardiol 2006;13(1):72-76.

24 Binbrek A, Elis A, Al-Zaibag M et al. Curr Ther Res 2006;67(1):21-43.

25 Stein E, Strutt KL, Miller E, Southworth H. Am J Cardiol 2003; 92:1287–1293.

26 Schneck DW, Knopp RH, Ballantyne CM et al. Am J Cardiol 2003; 91:33–41.

27 Leiter LA, Palmer M, Kallend D et al. Atheroscler Suppl 2005; 6(1):113 Abs W16-P-051.

28 Ballantyne C, Bertolami M, Garcia H et al. Am Heart J 2006;151:975.e1-975.e9

29 Olsson AG, McTaggart F, Raza A. Cardiovasc Drug Rev 2002;20:303–328.

30 Kritharides L. Eur Heart J Suppl 2004;6(Suppl A):A12–A18.

31 Shepherd J, Hunninghake DB, Barter B et al. Am J Cardiol 2003; 91(Suppl):11C–19C.

32 Schuster H, Fox JC. Exp Opin Pharmacother 2004;5:1187–1200.

33 Gordon D, Probstfield J, Garrison J et al. Circulation 1989;79:8-15.

34 Boden W. Am J Cardiol 2000;86 (suppl):19L-22L.

35 Manninen V, Elo O, Frick M et al. JAMA 1988;260:641-651.

36 Rubins H, Robins S, Collins D et al. N Engl J Med 1999;341:410-418

37 Betteridge D,GibsonJ.DiabeticMedicine2007;24(5):541-549.

38 Shepherd J et al. Am J Cardiol 2004;94:882-888

39 Shepherd J et al. Cardiology 2007;107(4):433-443

40 Data on File, Rosuvastatininformation.net

41 McAfee A, Ming E, Seeger J et al. Pharmacoepi Drug Safety 2006;15 (7):444-453

42 Goettsch W, Heintjes E, Kastelein J et al. Pharmacoepi Drug Safety 2006;15 (7):435-443

43 Kasliwal R, Wilton L, Shakir S. Circulation2006;113(8):e331 Abs P101 Abstract presented at the AHA 46th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, 2–5 March 2006, Phoenix, Arizona, USA.
CRESTOR is a trademark of the AstraZeneca group of companies.
Rosuvastatin calcium is manufactured underlicensefromShionogi&CO,Ltd,Osaka, Japan